DrugDashboards

Market view

pioglitazone and metformin hydrochloride · Tablet

12 marketed package NDCs · 2 active manufacturers

Most dispensed: 850 mg; HYDROCHLORIDE 15 mg · Tablet · #180 tablets/bottle · 500 mg; HYDROCHLORIDE 15 mg · Tablet · #180 tablets/bottle · 850 mg; HYDROCHLORIDE 15 mg · Tablet · #60 tablets/bottle · 500 mg; HYDROCHLORIDE 15 mg · Tablet · #60 tablets/bottle

All formsTablet (12)Tablet, Film Coated (3)

The short version

Just 2 companies supply this market — thin enough that a single exit would be felt immediately. The price is down 25% over the past year, to $0.2985 per unit.

Price range and competition

RSS: changes for this drug

Every company selling this drug reports its own price. The line follows the middle of the pack; the shaded band holds the middle half of companies — the wider it is, the more they disagree.

$0$0.5$1.00$1.50Jun 2017Sep 202602companies actively selling

Latest · Sep 2026 — typical price $0.2985 · middle half $0.275–$0.322 · full range $0.275–$0.322 · 4 products · 2 companies

middle half of companies’ pricestypical (median) pricewhat manufacturers charge wholesalers (WAMP)companies actively selling (bottom lane)Priced per unitⓘSource: CMS NADAC
ⓘ How this was built
Data sources
  • CMS NADAC weekly survey + monthly archives back to 2013 (data.medicaid.gov)
  • CMS Federal Upper Limit files (weighted AMP)
  • FDA NDC Directory (openFDA) — maker roster
Method

Each month's band spans the NADAC unit prices of every NDC of this drug (min, quartiles, median, max), split into brand and generic cohorts by FDA marketing category. Maker counts come from distinct labelers with the NDC actively listed.

Pipeline and calculations built by Claude (Fable 5) from the public datasets above. Educational only — verify against primary sources before acting.

What changed in the last 90 days

Every detected change for pioglitazone and metformin hydrochloride, newest first — price moves, shortages, recalls, and manufacturers entering or leaving. Detected by comparing each day’s federal data against the day before.

Same drug class

Other molecules FDA puts in Biguanide, with whether each is in shortage right now. Same class is not the same drug — substitution is a clinical decision, and this is a supply picture, not a recommendation.

Common questions

Is Pioglitazone and metformin hydrochloride in shortage right now?
No. FDA does not currently list Pioglitazone and metformin hydrochloride in shortage. This page is rebuilt every morning from FDA's shortage database, so a new posting appears here the day it is published.
Who makes Pioglitazone and metformin hydrochloride?
3 companies have marketed Pioglitazone and metformin hydrochloride in the last 30 days, according to the FDA NDC Directory. That is a thin market — if one stops making it, supply is at risk quickly. Every manufacturer and package is listed on this page.
What does Pioglitazone and metformin hydrochloride cost?
The typical pharmacy pays about $0.2985 per unit, based on the most recent CMS NADAC survey of actual acquisition costs. That is what the pharmacy pays for the drug itself — not the cash price, and not what an insurer is billed.

All marketed products

Expand a strength to see its dosage forms, then package sizes, then each manufacturer and NDC. Click an NDC for its full detail page.